Pharmaceutical Safety, Quality and Adverse-Effect Risks
First written in FY2020. 2 of 4 entries say "Restated". Latest entry: FY2025.
Wellneo Sugar moved to the "Worse" side of this theme in 2025, 1 year after the typical company in this theme (2024).
The whole theme swung hardest in 2026: 6 of 20 companies on the "Worse" side.
1 other company's latest entry also says "Reframed".
- FY2025ReframedAnnual report
「ツキオカフィルム製薬株式会社 handles materials related to pharmaceuticals and takes every possible precaution to ensure product safety, but」
The risks specific to the pharmaceutical business have been reframed as safety, quality and adverse-effect risks relating to materials used in pharmaceuticals, rather than risks relating to pharmaceuticals themselves. - FY2022RestatedAnnual report
「Our group company ツキオカフィルム製薬株式会社 operates a pharmaceutical business and takes every possible precaution to ensure product safety. However, if concerns arise regarding product safety, quality or adverse effects for any reason, product recalls, liability for damages and damage to the company's social reputation could affect our group's business performance and financial position.」
The company continues to disclose the safety, quality, adverse-effect, recall and liability risks specific to ツキオカフィルム製薬's pharmaceutical business. - FY2021RestatedAnnual report
「Our group company ツキオカフィルム製薬株式会社 operates a pharmaceutical business and takes every possible precaution to ensure product safety. However, if concerns arise regarding product safety, quality or adverse effects for any reason, product recalls, liability for damages and damage to the company's social reputation could affect our group's business performance and financial position.」
The company continues to disclose the safety, quality, adverse-effect, recall and liability risks specific to ツキオカフィルム製薬's pharmaceutical business. - FY2020First statedAnnual report
「Our group company ツキオカフィルム製薬株式会社 operates a pharmaceutical business and takes every possible precaution to ensure product safety. However, if concerns arise regarding product safety, quality or adverse effects for any reason, product recalls, liability for damages and damage to the company's social reputation could affect our group's business performance and financial position.」
The company explicitly disclosed for the first time the safety, quality, adverse-effect, recall and liability risks specific to ツキオカフィルム製薬's pharmaceutical business.